NeuroEM Therapeutics
PrivateLast Round
Series A
Jun 13, 2025
Est. Valuation
$14.3M
Total Funding Raised
$3.65M
Momentum Score
25 /100
Company Overview
NeuroEM Therapeutics is a therapeutic devices company developing a non-invasive, wearable head device that uses transcranial electromagnetic treatment to combat cognitive impairment caused by neurodegenerative conditions like Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Health IoT
Business Model
B2C
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroEM Therapeutics Comps
Public and private peers based on sector, stage, and business model.
NeuroEM Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 13, 2025 | ||||
| Grant | Jun 1, 2007 |
Key People
Founding team and executive leadership
NeuroEM Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rainwater Charitable Foundation | VC Round |
| Glass Foundation, Inc. | VC Round |
| NIH RADx | Grant |
| Founders Fund | Early Funding |
| Angel Investor Forum | Seed |
| Bluelake Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 6, 2025
Monthly visitors increased 48% MoM.
- Jun 13, 2025
$3.3M round led by Bluelake Ventures
NeuroEM Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuroEM Therapeutics's valuation, stock price, and market status.